The results of our FACS analysis demonstrated no difference in the expression levels of survivin-ΔEx3 or -2B, whereas survivin-WT was overexpressed in PBMCs (in particular CD14+ cells) from SSc patients compared with HCs. The gene discussed is BIRC5; the disease is systemic sclerosis.